Search

RESEARCH

University of Reading | Professor David S Leake

Researchers will investigate a potential new way to prevent the damaging effects of LDL cholesterol in arteries. ‘Bad’ LDL cholesterol contributes to artery disease, known as atherosclerosis, which causes heart attacks. Part of the proce...

RESEARCH

Queen Mary, University of London | Professor Adrian Hobbs

Professor Adrian Hobbs and his colleagues at Queen Mary University of London are looking for new ways to prevent and treat heart muscle damage after a heart attack. C-type natriuretic peptide (CNP) is a member of a family of naturally oc...

RESEARCH

University of Nottingham | Dr Andrew Benest

Angiogenesis – the process of growing new blood vessels – is important throughout our lives. But it can also contribute to many diseases when it goes wrong, by being too active (cancer) or not active enough (vessel disease). The ability to ...

RESEARCH

University College London | Dr Katy Sutcliffe

This social science project is seeking to advance the debate on informed consent. The prospect of having any kind of medical procedure can be stressful and worrying, but often if we find out more about it and know what to expect, some of t...

BHF Senior Cardiac Nurse Regina Giblin explains why you get cold hands and feet in winter and what signs to look out for, like numbness and pale or blotchy skin, that may indicate an underlying health condition.

A cheap and simple test, being developed with funding from us, is allowing quick and safe monitoring in children with a potentially deadly heart condition at Great Ormond Street Hospital.

RESEARCH

King's College London | Professor Catherine Shanahan

Dr Alexander Kapustin and his team at King’s College London are exploring how to boost the body’s natural ability to heal itself. Blood vessels have an in-built repair mechanism, in which cells called vascular smooth muscle cells (VSMCs) in...

RESEARCH

Queen Mary, University of London | Professor Timothy Warner

Anti-platelet drugs are taken by millions of people to protect against heart attacks and strokes. Routinely, people at particular risk receive aspirin plus an ADP (P2Y12) receptor antagonist. This is because most trials of antiplatelet ther...

A Leicestershire farmer has become the first person in the UK to join a trial, funded by us, to test whether the type 2 diabetes drug metformin can treat deadly abdominal aortic aneurysms